HYPR OBI
Live / Allowed — Notice of allowance issued (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99020582
- Mark type
- Design + words
- Filed
- 28 Jan 2025
- Published for opposition
- 30 Dec 2025
- Attorney of record
- Ran He
Goods and services
- Class 005 — Pharmaceuticals: Chemical reagents for medical or veterinary purposes; Vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated
Owner
- OBI PHARMA, INC., Taipei City, TW
- OBI PHARMA, INC., Taipei City, TW
Prosecution history
- 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Dec 2025 — PUBLISHED FOR OPPOSITION
- 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 04 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Jul 2025 — NON-FINAL ACTION E-MAILED
- 24 Jul 2025 — NON-FINAL ACTION WRITTEN